Condition

Vitiligo clinical trials and research

• 19Clinical trials
• 14NIH research projects
• 1New in 30 days
• 10Countries

Newest Vitiligo clinical trials

All recruiting trials (19)

• crisaborole 2% versus tacrolimus 0.1% with light therapy for facial vitiligo

  This study tests whether applying crisaborole 2% ointment can improve stable facial vitiligo in children and adults and whether it is as safe and effective as tacrolimus 0.1% when combined with light therapy.

  Recruiting Phase 3 Cairo University · Cairo · NCT07904910

• Imaging vitiligo lesions with polarized, sub-ultraviolet, and ultraviolet dermoscopy

  This study tests whether advanced light-based skin imaging can reveal details of vitiligo spots in adults more clearly than standard polarized dermoscopy.

  Recruiting Istanbul Training and Research Hospital · Istanbul · NCT07846969

• MH004 Ointment in non-segmental vitiligo: a phase 3 trial

  A 12-month randomized trial tests MH004 ointment to see if it helps facial vitiligo more than a placebo in people aged 12 to 75.

  Recruiting Phase 3 Minghui Pharmaceutical (Hangzhou) Ltd · Beijing, Beijing Municipality · NCT07682506

• NSV: Vitiligo Drug Safety and Effectiveness Registry for Adults and Teens

  This registry tracks adults and teens with nonsegmental vitiligo to see how usual treatments work and how safe they are over time in real-world dermatology care.

  Recruiting CorEvitas · Waltham, Massachusetts · NCT07659418

• D-2570 in Non-Segmental Vitiligo (Phase 2)

  This study tests whether D-2570 can improve skin discoloration in adults with non-segmental vitiligo compared with a placebo.

  Recruiting Phase 2 InventisBio Co., Ltd · Shanghai, Shanghai Municipality · NCT07625891

• LY4005130 for adults with non-segmental vitiligo

  This study will test whether intravenous LY4005130 is safe and what side effects it may cause in adults with non-segmental vitiligo.

  Recruiting at 35 sites Phase 2 Eli Lilly and Company · Phoenix, Arizona and 34 other locations · NCT07533019

• Micro-needling with 5‑fluorouracil versus strong topical steroid for limited vitiligo

  This trial will test whether micro-needling plus 5‑fluorouracil or a potent topical steroid works better to restore pigment in people with limited, stable vitiligo.

  Recruiting Early Phase 1 Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan · Chak Eighty-seven -Twelve Left · NCT07398807

• Phase 1 proof-of-concept test of CGB-600 gel for non-segmental vitiligo on the face and neck

  This trial will try a twice-daily CGB-600 gel to see if it reduces vitiligo on the face and neck in adults 18–60 and to check for side effects.

  Recruiting at 2 sites Phase 1 CAGE Bio Inc. · Ankara, Turkey and 1 other locations · NCT07357870

• Betamethasone phonophoresis to help repigment vitiligo patches

  This trial will try using betamethasone delivered with therapeutic ultrasound (phonophoresis) to help people with vitiligo regain skin pigment.

  Recruiting Cairo University · Cairo · NCT07267273

• Transplanting your own skin cells to restore pigment in vitiligo

  This procedure will try transplanting a suspension made from your own skin cells to restore pigment in people aged 8–65 with stable vitiligo that hasn't improved with medicine or light therapy.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07187882

• Factors influencing how well ruxolitinib cream works in vitiligo

  This study tests whether patient and disease characteristics affect how well ruxolitinib 1.5% cream works for people aged 12 and older with non‑segmental vitiligo covering under 10% of the body.

  Recruiting Peking University Third Hospital · Beijing · NCT07153666

• Combination of Ritlecitinib and nbUVB for Vitiligo

  This study tests if adding narrowband UVB to ritlecitinib helps treat vitiligo better than ritlecitinib alone in adults with non-segmental vitiligo.

  Recruiting at 5 sites Phase 2 Centre Hospitalier Universitaire de Nice · Nice, Alpes-Maritime and 4 other locations · NCT07152626

• Comparing needling and microneedling treatments for vitiligo

  This study is testing whether needling or microneedling treatments, followed by light therapy, can help people with stable vitiligo see better skin color improvement.

  Recruiting Phase 4 Khyber Teaching Hospital · Peshawar, Khyber Pakhtunkhwa · NCT06991972

• Oral tacrolimus versus dexamethasone micro‑pulse for rapidly progressing pediatric vitiligo

  This trial tests whether daily oral tacrolimus or weekend dexamethasone pulses better control rapidly spreading vitiligo in children aged 4–12.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT06900777

• Topical Ruxolitinib for treating vitiligo in adults

  This study is testing if a new cream called Ruxolitinib can help adults with vitiligo on their face and neck feel better when other treatments haven't worked.

  Recruiting Phase 2/3 Hospital Authority, Hong Kong · Hong Kong · NCT06719024

• Testing TEV-53408 for treating vitiligo

  This study is testing a new treatment called TEV-53408 to see if it can help adults with vitiligo improve their skin color over an 84-week period.

  Recruiting at 7 sites Phase 1 Teva Branded Pharmaceutical Products R&D, Inc. · Scottsdale, Arizona and 12 other locations · NCT06625177

• Using Upadacitinib to Improve Vitiligo Treatment

  This study is testing if adding a medication called upadacitinib after a skin treatment can help adults with vitiligo see better results.

  Recruiting Jilin University · Changchun, Jilin · NCT06454461

• Effervescent powder treatment for vitiligo

  This study is testing a new effervescent powder treatment for stable vitiligo to see if it works better than regular powder in helping people with skin discoloration.

  Recruiting Phase 4 Al-Azhar University · Cairo · NCT05536856

• Examining the gut and skin microbiome in vitiligo patients

  This study looks at the gut and skin bacteria in people with vitiligo to see if their microbiomes are different from those without the condition.

  Recruiting Northwestern University · Chicago, Illinois · NCT03577327

NIH-funded research (14)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Cell communications and tissue memory in vitiligo

  This grant looks at how skin cells talk to each other and how these conversations may drive vitiligo, with the goal of finding new ways to treat or manage the condition.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-11375165

• Autoreactive T Cell Function in Vitiligo

  A study in people with vitiligo and related models aims to understand how skin-homing T cells drive pigment loss and how this knowledge could lead to better treatments.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-11375161

• Understanding why the immune system targets skin in vitiligo and how this causes lasting damage

  A research program is studying how immune cells attack pigment cells in the skin of people with vitiligo and what drives this autoimmune process.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-11375155

• Understanding why some vitiligo patches repigment while others stay white

  This grant studies why certain vitiligo patches repigment in some areas after treatment and why others persist, aiming to make treatments faster and more even.

  NIH research University of California-Irvine · Irvine, United States · NIH-11345798

• Understanding Cell Communication and Tissue Memory in Vitiligo

  This project aims to understand how skin cells communicate and remember past events in people with vitiligo, hoping to find new ways to treat the condition.

  NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11159473

• Understanding T Cells in Vitiligo

  This research explores how certain immune cells, called T cells, cause the skin condition vitiligo, which leads to white spots on the skin.

  NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11159470

• Understanding Autoimmunity in Vitiligo

  This project aims to understand how the immune system attacks skin cells in people with vitiligo, causing white patches.

  NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11159454

• Understanding how local skin factors affect repigmentation in vitiligo

  This study is looking into why some spots on the skin regain color after treatment for vitiligo while others don’t, and it’s for people with vitiligo who want to understand how their skin can respond better to therapies.

  NIH research University of California-Irvine · Irvine, United States · NIH-11097219

• New treatment options for vitiligo

  This study is looking at a new treatment for vitiligo, a condition that causes skin to lose its color, by targeting a specific protein that plays a role in the disease, with the goal of finding effective and affordable options to help improve the lives of people with vitiligo.

  NIH research Aohbio Corporation · Athens, United States · NIH-11005527

• Understanding how cells communicate in vitiligo

  This study is looking at how skin cells talk to each other and how that communication goes wrong in vitiligo, a condition that causes skin to lose its color, with the hope of finding new ways to treat it.

  NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-10868483

• Understanding how T cells attack skin cells in vitiligo

  This study is looking at how certain immune cells called T cells behave in people with vitiligo, a condition that causes skin color loss, to better understand what happens in the body and find new ways to help treat it.

  NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-10868481

• Understanding how the immune system attacks skin cells in vitiligo

  This study is looking into how vitiligo works by examining skin samples from patients to see how the immune system affects the cells that give skin its color, with the hope of finding better treatments for vitiligo and similar conditions.

  NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-10868476

• Topical treatment for vitiligo using a selective MC1R agonist

  This study is testing a new cream that might help people with vitiligo regain their skin color by targeting a specific receptor in the skin, and it will keep track of how well it works and how your skin feels during the treatment.

  NIH research Mc1r Ventures LLC · Cincinnati, United States · NIH-10759768

• Investigating how T cells move in the skin and their role in vitiligo and melanoma

  This study is looking at how a specific signal called NKG2D helps T cells move around in the body, especially in skin conditions like vitiligo and melanoma, to find better ways to treat people dealing with these issues.

  NIH research H. Lee Moffitt Cancer Ctr & Res Inst · Tampa, United States · NIH-10608358

Related topics

Quick answers

How many Vitiligo clinical trials are recruiting right now?

19, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in China (7 trials), United States (4 trials), Egypt (3 trials), Pakistan (2 trials), Turkey (Türkiye) (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 2, Phase 4: 2, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →